Latest News

FDA and DoD formalize collaboration to advance medical products

November 2, 2018 | FDA News Release

Today, the U.S. Food and Drug Administration and the Department of Defense’s (DoD) Office of Health Affairs signed a Memorandum of Understanding regarding medical product development and assessment. This builds upon the work of both agencies to foster and prioritize the efficient development of safe and effective medical products intended to save the lives of American service members.

Back to top

New law extends ADUFA, funding FDA review of medicines for pets and livestock

August 14, 2018 | Washington Examiner

President Trump has signed a bill into law that extends a program funding medicines for pets and livestock. The legislation, collectively known as the Animal Drug and Animal Generic Drug User Fee Amendments of 2018, or ADUFA, charges fees for drug and device applications and uses that money to speed up their review. That way, products can head to market faster, and animal owners can have less expensive or more effective drugs to use on animals who fall ill.

Back to top

DOD, FDA Partner to Develop Medical Products for Warfighters

January 16, 2018 | US Department of Defense

The Defense Department and Food and Drug Administration have launched a joint pilot program to prioritize efficiently developing safe and effective medical products to save the lives of U.S. warfighters.

EDITOR'S NOTE: One of Expanesthetics' programs may qualify for this DOD/FDA program, post-pilot.

Back to top